Delivery Order SPE2DB20D9135-SPE2DB25FZW77
Award Date
4/21/25
Potential Completion Date
5/12/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $10,093.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of December 9, 2024, is for the delivery of Nuplazid 34 mg capsules. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,093.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which runs through December 31, 2025. The contract is for the provision of...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product, with a period of performance ending on April 9, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,729 contract is for the delivery of Nuplazid 34 mg capsules by January 3, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide range...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract, valued at $10,093.50, to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S to support the medical supply needs of the agency. This delivery order falls under DMS Pharmaceutical Group's larger indefinite delivery contract, SPE2DB, with the Defense Logistics Agency, which has a potential value...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,364.50, covers the supply of the drug Nuplazid 34 mg capsules with a completion date of July 22, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,364.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product, with a period of performance through November 14, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,458.51 firm fixed-price delivery order is for the provision of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product, with a performance period through April 8, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,093.50, is for the delivery of the prescription drug Nuplazid 34 mg capsules with a completion date of December 24, 2024. DMS Pharmaceutical Group Inc. also holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,093.50 fixed-price delivery order is for the supply of Nuplazid 34 mg capsules, and is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue firm fixed-price delivery orders to...